No shared counterparties.
| Stage | VICR | % of rev | VRT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $197M | 100.00% | $4.3B | 100.00% | VRT ×21.88 |
| Gross profit | $135M | 68.33% | $1.6B | 38.11% | VICR +30.2pp |
| Operating income | $72M | 36.60% | $984M | 22.81% | VICR +13.8pp |
| Pre-tax income | $79M | 39.94% | $995M | 23.07% | VICR +16.9pp |
| Net income | $63M | 32.13% | $765M | 17.73% | VICR +14.4pp |
| Stage | VICR | VRT | Gap · A − B |
|---|---|---|---|
| Revenue | $197M100.00% | $4.3B100.00% | VRT ×21.88 |
| Gross profit | 68.33%$135M | 38.11%$1.6B | VICR +30.2pp |
| Operating income | 36.60%$72M | 22.81%$984M | VICR +13.8pp |
| Pre-tax income | 39.94%$79M | 23.07%$995M | VICR +16.9pp |
| Net income | 32.13%$63M | 17.73%$765M | VICR +14.4pp |